Biodegradable microparticles covalently linked to surface antigens of the scuticociliate parasite P. dicentrarchi promote innate immune responses in vitro

Fish and Shellfish Immunology

Volumn 34, Issue 1, 2013, Pages 236-243

  Leon Rodriguez L ^a   Luzardo alvarez A ^a   Blanco Mendez J ^a   Lamas, J ^a   Leiro, J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adjuvants; Biodegradable microspheres; Innate immune response; Leukocytes; Membrane antigens; Mice; Proinflammatory cytokines; Scuticociliates; Turbot

Indexed keywords

MURINAE; MUS; PHILASTERIDES DICENTRARCHI; SCOPHTHALMIDAE; SCOPHTHALMUS MAXIMUS; SCUTICOCILIATIA;

EID: 84871609211     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2012.10.029     Document Type: Article

References (64)

1. Iglesias R., Paramá A., álvarez M.F., Leiro J., Fernández J., Sanmartín M.L. Philasterides dicentrarchi (Ciliophora, Scuticociliatida) as the causative agent of scuticociliatosis in farmed turbot Scophthalmus maximus in Galicia (NW Spain). Disease of Aquatic Organisms 2001, 46:47-55.
2. Sitjà-Bobadilla A., Palenzuela O., álvarez-Pellitero P. Immune response of turbot, Psetta maxima (L.) (Pisces: Teleostei), to formalin-killed scuticociliates (Ciliophora) and adjuvanted formulations. Fish and Shellfish Immunology 2008, 24:1-10.
3. Sanmartín M.L., Paramá A., Castro R., Cabaleiro S., Leiro J., Lamas J. Vaccination of turbot against the protozoan parasite Philasterides dicentrarchi. Effects on antibody production and protection. Journal of Fish Diseases 2008, 31:135-140.
4. Lamas J., Sanmartín M.L., Paramá A.I., Castro R., Cabaleiro S., Ruiz de Ocenda M.V., Barja J.L., Leiro J. Optimization of an inactivated vaccine against a scuticociliate parasite of turbot: effect of antigen, formalin and adjuvant concentration on antibody response and protection against the pathogen. Aquaculture 2008, 278:22-26.
5. Piazzon C., Lamas J., Castro R., Budiño B., Cabaleiro S., Sanmartín M.L. Antigenic and cross-protection studies on two turbot scuticociliate isolates. Fish and Shellfish Immunology 2008, 25:417-424.
6. Jenkins M.C. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Veterinary Parasitology 2001, 101:291-310.
7. De Temmerman M.L., Rejman J., Demeester J., Irvine D.J., Gander B., De Smedt S.C. Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discovery Today 2011, 16:569-582.
8. Pashine A., Valiante N.M., Ulmer J.B. Targeting the innate immune response with improved vaccine adjuvants. Nature Medicine 2005, 11(4 Suppl):S63-S68.
9. Iglesias R., Paramá A., álvarez M.F., Leiro J., Ubeira F.M., Sanmartín M.L. Philasterides dicentrarchi (Ciliophora: Scuticociliatida) expresses surface immobilization antigens that probably induce protective immune responses in turbot. Parasitology 2003, 126:125-134.
10. Aucouturier J., Dupuis L., Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001, 19:2666-2672.
11. Meeusen E.N., Walker J., Peters A., Pastoret P.P., Jungersen G. Current status of veterinary vaccines. Clinical Microbiology Reviews 2007, 20:489-510.
12. Petrovsky N., Aguilar J.C. Vaccine adjuvants: Current state and future trends. Immunology and Cell Biology 2004, 82:488-496.
13. Mutoloki S., Reite O.B., Brudeseth B., Tverdal A., Evensen O. A comparative immunopathological study of injection site reactions in salmonids following intraperitoneal injection with oil-adjuvanted vaccines. Vaccine 2006, 24:578-588.
14. Jiao X.D., Cheng S., Hu Y.-H., Sun L. Comparative study of the effects of aluminium adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen. Vaccine 2010, 28:1832-1837.
15. Jalil R., Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. Journal of Microencapsulation 1990, 7:297-325.
16. Jain S., O'Hagan D.T., Singh M. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant. Expert Review of Vaccines 2011, 10:1731-1742.
17. Xiang S.D., Scholzen A., Minigo G., David C., Apostolopoulos V., Mottram P.L., Plebanski M. Pathogen recognition and development of particulate vaccines: does size matter?. Methods 2006, 40:1-9.
18. Wikingsson L., Sjöholm I. Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice. Vaccine 2002, 20:3355-3363.
19. Singh M., Kazzaz J., Chesko J., Soenawan E., Ugozzoli M., Giuliani M., Pizza M., Rappouli R., O'Hagan D.T. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. Journal of Pharmaceutical Sciences 2004, 93:273-282.
20. Wilkinson K.A., Belisle J.T., Mincek M., Wilkinson R.J., Toossi Z. Enhancement of the human T cell response to culture filtrate fractions of Mycobacterium tuberculosis by microspheres. Journal of Immunological Methods 2000, 235:1-9.
21. León-Rodríguez L., Luzardo-álvarez A., Blanco-Méndez J., Lamas J., Leiro J. A vaccine based on biodegradable microspheres induces protective immunity against scuticociliatosis without producing side effects in turbot. Fish and Shellfish Immunology 2012, 33:21-27.
22. Budiño B., Lamas J., Pata M.P., Arranz J.A., Sanmartín M.L., Leiro J. Intraspecific variability in several isolates of Philasterides dicentrarchi (syn. Miamiensis avidus), a scuticociliate parasite of farmed turbot. Veterinary Parasitology 2011, 175:260-272.
23. Paramá A., Iglesias R., álvarez M.F., Leiro J., Aja C., Sanmartín M.L. Philasterides dicentrarchi (Ciliophora, Scuticociliatida): experimental infection and possible routes of entry in farmed turbot (Scophthalmus maximus). Aquaculture 2003, 217:73-80.
24. Castro R., Couso N., Obach A., Lamas J. Effect of different β-glucans on the respiratory burst of turbot (Psetta maxima) and gilthead seabream (Sparus aurata) phagocytes. Fish and Shellfish Immunology 1999, 9:529-541.
25. Leiro J., Siso M.I.G., Ortega M., Santamarina M.T., Sanmartín M.L. A factorial experimental design for investigation of the effects of temperature, incubation time, and pathogen-to-phagocyte ratio on in vitro phagocytosis by turbot adherent cells. Comparative Biochemistry and Physiology 1995, 112C:215-220.
26. 15N] nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
27. Castro R., Zarra I., Lamas J. Water-soluble seaweed extracts modulate the respiratory burst activity of turbot phagocytes. Aquaculture 2004, 229:67-78.
28. Paramá A., Castro R., Arranz J.A., Sanmartín M.L., Lamas J., Leiro J. Scuticociliate cysteine proteinases modulate turbot leucocyte functions. Fish and Shellfish Immunology 2007, 23:945-956.
29. Leiro J.M., Alvarez E., Arranz J.A., Siso I.G., Orallo F. In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochemical Pharmacology 2003, 65:1361-1371.
30. Leiro J.M., Varela M., Piazzon M.C., Arranz J.A., Noya M., Lamas J. The anti-inflammatory activity of the polyphenol resveratrol may be partially related to inhibition of tumour necrosis factor-alpha (TNF-alpha) pre-mRNA splicing. Molecular Immunology 2010, 47:1114-1120.
31. Bramwell V.W., Perrie Y. Particulate delivery systems for vaccines. Critical Reviews in Therapeutic Drug 2005, 22:151-214.
32. Hubbell J.A., Thomas S.N., Swartz M.A. Materials engineering for immunomodulation. Nature 2009, 462:449-460.
33. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annual Review of Immunology 1997, 15:821-850.
34. Burgdorf S., Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Current Opinion in Immunology 2008, 20:89-95.
35. O'Hagan D.T., Rappuoli R. The safety of vaccines. Drug Discovery Today 2004, 9. 846-54.
36. O'Hagan D.T., Ott G.S., Van Nest G. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. Molecular Medicine Today 1997, 3:69-75.
37. O'Hagan D.T. Microparticles and polymers for the mucosal delivery of vaccines. Advanced Drug Delivery Reviews 1998, 34:305-320.
38. O'Hagan D.T., Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Review of Vaccines 2003, 2:269-283.
39. Schwendeman S.P. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Critical Reviews in Therapeutic Drug Carrier Systems 2002, 19:73-98.
40. Li X.Y., Kong X.Y., Shi S., Zheng X.L., Guo G., Wei Y.Q., Qian Z.Y. Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnology 2008, 8:89.
41. Sloat B.R., Sandoval M.A., Hau A.M., He Y., Cui Z. Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. Journal of Controlled Release 2010, 141:93-100.
42. Li X., Sloat B.R., Yanasarn N., Cui Z. Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design. European Journal of Pharmaceutics and Biopharmaceutics 2011, 78:107-116.
43. Kumar A., Li X., Sandoval M.A., Rodriguez L.B., Sloat B.R., Cui Z. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. International Journal of Nanomedicine 2011, 6:1253-1264.
44. Chua B.Y., Al Kobaisi M., Zeng W., Mainwaring D., Jackson D.C. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines. Molecular Pharmacology 2012, 9:81-90.
45. Di Carlo F.J., Fiore J.V. On the composition of zymosan. Science 1958, 127:756-757.
46. Fuentes A.L., Millis L., Sigola L.B. Laminarin, a soluble beta-glucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis. International Immunopharmacology 2011, 11:1939-1945.
47. Hibbs J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for l-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987, 235:473-476.
48. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Aït-Yahia S., Brière F., Zlotnik A., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Journal of Experimental Medicine 1998, 188:373-386.
49. Narumi S., Finke J.H., Hamilton T.A. Interferon-γ and interleukin-2 synergize to induce selective monokine expression in murine peritoneal macrophages. Journal of Biological Chemistry 1990, 265:7036-7040.
50. Eisenstein T.K. Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Microbes and Infection 2001, 3:1223-1231.
51. Basu R., Bhaumik S., Basu J.M., Naskar K., De T., Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. Journal of Immunology 2005, 174:7160-7171.
52. Khirina N.P., Vasil'eva I.A., Stepanov A.V. Postvaccinal changes in the nitric oxide system after immunization with live dry tularemia vaccine. Bulletin of Experimental Biology and Medicine 2011, 151:55-57.
53. Jiang F., Zhang Y., Dusting G.J. NADPH oxidase-mediated redox signalling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacological Reviews 2011, 63:218-242.
54. Fabiani R., Pampanella L., Minelli A., Mezzasoma I., Vecchiarelli A., Morozzi G. Effect of airborne particulate extracts on monocyte oxidative metabolism. Journal of Environmental Pathology, Toxicology and Oncology 1997, 16:195-199.
55. Vignais P.V. The superoxide-generating NADPH oxidase: structural aspects and activation mechanisms. Cellular and Molecular Life Sciences 2002, 59:1428-1459.
56. Vlahos R., Stambas J., Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends in Pharmacological Sciences 2012, 33:3-8.
57. Yan W., Chen W., Huang L. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine. Journal of Controlled Release 2008, 130:22-28.
58. Robinson J.M. Phagocytic leukocytes and reactive oxygen species. Histochemistry and Cell Biology 2009, 131:465-469.
59. Bréchard S., Tschirhart J. Regulation of superoxide production in neutrophils: role of calcium influx. Journal of Leukocyte Biology 2008, 84:1223-1237.
60. Forman H.J., Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. American Journal of Respiratory and Critical Care Medicine 2002, 166:S4-S8.
61. Méndez-Samperio P., Pérez A., Alba L. Reactive oxygen species-activated p38/ERK 1/2 MAPK signaling pathway in the Mycobacterium bovis bacillus Calmette Guérin (BCG)-induced CCL2 secretion in human monocytic cell line THP-1. Archives of Medical Research 2010, 41:579-585.
62. Dröge W. Free radicals in the physiological control of cell function. Physiological Reviews 2002, 82:47-95.
63. Dehghani F., Haji Molla Hoseini M., Memarnejadian A., Yeganeh F., Rezaie A.M., Khaze V., Sattari M., Darbandi Tamijani H., Labibi F., Mossaffa N. Immunomodulatory activities of chitin microparticles on Leishmania major-infected murine macrophages. Archives of Medical Research 2011, 42:572-576.
64. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annual Review of Immunology 2010, 28:57-78.